On the incorporation of chemical-specific information in risk assessment.

This paper describes the evolution of chemical risk assessment from its early dependence on generic default approaches to the current situation in which mechanistic and biokinetic data are routinely incorporated to support a more chemical-specific approach. Two methodologies that have played an important role in this evolution are described: mode-of-action evaluation and physiologically based biokinetic (PBBK) modelling. When used together, these techniques greatly increase the opportunity for the incorporation of biokinetic and mechanistic data in risk assessment. The resulting risk assessment approaches are more appropriately tailored to the specific chemical and are more likely to provide an accurate assessment of the potential hazards associated with human exposures. The appropriate application of PBBK models in risk assessment demands well-formulated statements about the chemical mode of action. It is this requirement for an explicit, mechanistic hypothesis that gives biologically motivated models their power, but at the same time serves as the greatest impediment to the acceptance of a chemical-specific risk assessment approach by regulators. The chief impediment to the regulatory acceptance and application of PBBK models in risk assessment is concern about uncertainties associated with their use. To some extent such concerns can be addressed by the development of generally accepted approaches for model evaluation and quantitative uncertainty analysis. In order to assure the protection of public health while limiting the economic and social consequences of over-regulation, greater dialogue between researchers and regulators is crucially needed to foster an increased use of emerging scientific information and innovative methods in chemical risk assessments.

[1]  M E Andersen,et al.  Saturable metabolism and its relationship to toxicity. , 1981, Critical reviews in toxicology.

[2]  Melvin E Andersen,et al.  New directions in incidence-dose modeling. , 2005, Trends in biotechnology.

[3]  H J Clewell,et al.  Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. , 1991, Toxicology and applied pharmacology.

[4]  H. Clewell,et al.  A Pharmacokinetic Model of the Intracellular Dosimetry of Inhaled Nickel , 2007, Journal of toxicology and environmental health. Part A.

[5]  Harvey J Clewell,et al.  An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  H J Clewell,et al.  Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[7]  Yu-Mei Tan,et al.  Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  J D Graham,et al.  Expert scientific judgment and cancer risk assessment: a pilot study of pharmacokinetic data. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  Melvin E. Andersen,et al.  Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling , 2004 .

[10]  D. J. Bates,et al.  Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice. , 1998, Toxicology and applied pharmacology.

[11]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[12]  R. Stone Counting the Cost of London's Killer Smog , 2002, Science.

[13]  A. Renwick,et al.  The use of surrogate endpoints to assess potential toxicity in humans. , 2001, Toxicology letters.

[14]  W. Slob,et al.  Mathematical modelling and quantitative methods. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  K. R. Smith,et al.  Paracelsus and Goethe: founding fathers of environmental health. , 2000, Bulletin of the World Health Organization.

[16]  M. Andersen,et al.  Pharmacokinetic Modeling of Manganese in the Rat IV: Assessing Factors that Contribute to Brain Accumulation During Inhalation Exposure , 2008, Journal of toxicology and environmental health. Part A.

[17]  H W Leung,et al.  Development and utilization of physiologically based pharmacokinetic models for toxicological applications. , 1991, Journal of toxicology and environmental health.

[18]  Hugh A Barton,et al.  Computational Pharmacokinetics During Developmental Windows of Susceptibility , 2005, Journal of toxicology and environmental health. Part A.

[19]  Harvey J Clewell,et al.  The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. , 2007, Regulatory toxicology and pharmacology : RTP.

[20]  A. Renwick Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.

[21]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[22]  Melvin E. Andersen,et al.  Physiologically Based Pharmacokinetic Modeling , 2010 .

[23]  M. Andersen,et al.  Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. , 1999, Neurotoxicology.

[24]  G. W. Jepson,et al.  Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters. , 1994, Environmental health perspectives.

[25]  H J Clewell,et al.  Biologically motivated models for chemical risk assessment. , 1989, Health physics.

[26]  H Boeing,et al.  The contribution of epidemiology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  R A Corley,et al.  Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans. , 1994, Toxicology and applied pharmacology.

[28]  Richard D. Thomas Drinking Water and Health , 1986 .

[29]  Harvey J. Clewell,et al.  Improving the Development and Use of Biologically Based Dose Response Models (BBDR) in Risk Assessment , 2001 .

[30]  H. Matthews,et al.  Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms. , 1992, Toxicology and applied pharmacology.

[31]  M E Andersen,et al.  Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[32]  Harvey J. Clewell Conference on chemical risk assessment in the Department of Defense (DoD) : science, policy, and practice , 1992 .

[33]  J Kleiner,et al.  Assessment of intake from the diet. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[34]  Melvin E. Andersen,et al.  Physiologically Based Pharmacokinetic Modeling : Science and Applications , 2005 .

[35]  A G Renwick,et al.  Hazard characterisation of chemicals in food and diet. dose response, mechanisms and extrapolation issues. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  J W Bridges,et al.  Hazard identification by methods of animal-based toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[37]  Gunnar Johanson,et al.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation , 2005, Archives of Toxicology.

[38]  R. J. Lutz,et al.  A review of the applications of physiologically based pharmacokinetic modeling , 1979, Journal of Pharmacokinetics and Biopharmaceutics.

[39]  Harvey J Clewell,et al.  Perchlorate and Radioiodide Kinetics Across Life Stages in the Human: Using PBPK Models to Predict Dosimetry and Thyroid Inhibition and Sensitive Subpopulations Based on Developmental Stage , 2007, Journal of toxicology and environmental health. Part A.

[40]  Hugh A Barton,et al.  Framework for Evaluation of Physiologically‐Based Pharmacokinetic Models for Use in Safety or Risk Assessment , 2004, Risk analysis : an official publication of the Society for Risk Analysis.

[41]  K M Lee,et al.  Physiologically based pharmacokinetic model for chronic inhalation of 2-butoxyethanol. , 1998, Toxicology and applied pharmacology.

[42]  H J Clewell,et al.  Applying simulation modeling to problems in toxicology and risk assessment--a short perspective. , 1995, Toxicology and applied pharmacology.

[43]  Renwick,et al.  Human variability and noncancer risk assessment- An analysis of the default uncertainty factor , 1998, Regulatory toxicology and pharmacology : RTP.

[44]  H J Clewell,et al.  Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.

[45]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[46]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[47]  M. Andersen,et al.  Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.

[48]  Division on Earth Risk Assessment in the Federal Government: Managing the Process , 1983 .

[49]  B J Blaauboer,et al.  The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary. , 2003, Toxicology letters.

[50]  M E Andersen,et al.  Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. , 1990, Toxicology and applied pharmacology.

[51]  I. Hertz-Picciotto,et al.  Risk characterisation of chemicals in food and diet. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[52]  J. Molnar,et al.  Physiologically Based Pharmacokinetic Modeling???Science and Applications , 2006 .

[53]  Harvey J Clewell,et al.  Use of a Physiologically Based Pharmacokinetic Model to Identify Exposures Consistent With Human Biomonitoring Data for Chloroform , 2006, Journal of toxicology and environmental health. Part A.

[54]  Torsten Teorell,et al.  Kinetics of distribution of substances administered to the body, II : The intravascular modes of administration , 1937 .

[55]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[56]  Ellen J. O'Flaherty,et al.  Interspecies Conversion of Kinetically Equivalent Doses1 , 1989 .

[57]  H J Clewell,et al.  Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform. , 1996, Toxicology.

[58]  Richard A. Corley,et al.  Physiologically Based Pharmacokinetics and the Dermal Absorption of 2-Butoxyethanol Vapor by Humans , 1997 .

[59]  H A el-Masri,et al.  Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment. , 1995, Toxicology.

[60]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .

[61]  Joseph A. Tatman,et al.  Dealing with Uncertainty in Chemical Risk Analysis , 1990 .

[62]  Stephen S. Olin,et al.  Low-dose extrapolation of cancer risks : issues and perspectives , 1995 .

[63]  M Balls,et al.  Methods of in vitro toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.